AMGEN TO PRESENT AT THE 33rd ANNUAL OPPENHEIMER HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the 2023 Oppenheimer Healthcare Conference on March 13, 2023, at 2:00 p.m. ET. Senior Vice President Susan Sweeney will represent the company. The presentation will be accessible through a live webcast for media, investors, and the public, with a replay available for 90 days post-event. Amgen focuses on developing innovative human therapeutics, using advanced genetics to address serious illnesses and unmet medical needs. A biotechnology leader since 1980, Amgen is a part of the Dow Jones Industrial Average and Nasdaq-100, recognized for its sustainability and employer ranking.

THOUSAND OAKS, Calif., March 9, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2023 Oppenheimer Healthcare Conference at 2:00 p.m. ET on Monday, March 13, 2023. Susan Sweeney, senior vice president, Global Marketing, Access and Capabilities at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2022, Amgen was named one of the "World's Best Employers" by Forbes and one of "America's 100 Most Sustainable Companies" by Barron's.

For more information, visit Amgen.com and follow us on Twitter, LinkedIn, Instagram, TikTok and YouTube.  

CONTACT: Amgen, Thousand Oaks
Jessica Akopyan, 805-447-0974 (media) 
Arvind Sood, 805-447-1060 (investors) 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-33rd-annual-oppenheimer-healthcare-conference-301768494.html

SOURCE Amgen

FAQ

When will Amgen present at the Oppenheimer Healthcare Conference?

Amgen will present at the 2023 Oppenheimer Healthcare Conference on March 13, 2023, at 2:00 p.m. ET.

Who will represent Amgen at the conference?

Susan Sweeney, Senior Vice President of Global Marketing, Access, and Capabilities, will represent Amgen.

How can I watch Amgen's presentation at the conference?

The presentation will be available via a live webcast on Amgen's website.

Is there a replay available for Amgen's conference presentation?

Yes, the webcast will be archived and available for replay for at least 90 days after the event.

What is Amgen's focus in the biotechnology sector?

Amgen focuses on discovering and delivering innovative therapies for serious illnesses using advanced human genetics.

What recognition has Amgen received recently?

Amgen was named one of the World's Best Employers by Forbes and one of America's 100 Most Sustainable Companies by Barron's in 2022.